{
    "name": "fluorescein ophthalmic",
    "comment": "OTC",
    "other_names": [
        "BioGlo",
        "Fluorets",
        "Ful-Glo"
    ],
    "classes": [
        "Diagnostics",
        "Ophthalmics"
    ],
    "source": "https://reference.medscape.com/drug/bioglo-fluorets-fluorescein-ophthalmic-999591",
    "pregnancy": {
        "common": [
            "There is insufficient data with the use of fluorescein in pregnant women to inform a drug-associated risk",
            "Adequate animal reproduction studies have not been conducted with fluorescein; fluorescein should only be given to a pregnant woman if clearly needed"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "Intravenous administration of a single dose of fluorescein to pregnant rats resulted in rapid distribution into the amniotic fluid and fetus"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "Fluorescein injection has been demonstrated to be transferred into human milk for up to 4 days following IV administration"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to components or mercury-containing compounds; history of hypersensitivity to fluorescein sodium"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Severe local tissue damage, including phlebitis, skin sloughing, toxic neuritis, may occur from extravasation; use caution; discontinue immediately if extravasation occurs",
                "Use caution and monitor closely in patients with history of hypersensitivity, allergies, or asthma",
                "Skin may turn yellow within few minutes of administration and fade in 6-12 hr; urine may appear bright yellow for 24-36 hr",
                "Not for intrathecal or arterial administration",
                "Nausea and/or vomiting and gastrointestinal distress may occur commonly within few minutes following injection; may subside within 10 min",
                "Remove contact lenses before use to avoid staining; after exam, flush eye with saline eye drops and wait at least 1 hr before reinserting contact lenses"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Seizure",
            "percent": null
        },
        {
            "name": "Dizziness",
            "percent": null
        },
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "Cardiac arrest",
            "percent": null
        },
        {
            "name": "rare",
            "percent": null
        },
        {
            "name": "Shock",
            "percent": null
        },
        {
            "name": "Hypotension",
            "percent": null
        },
        {
            "name": "Syncope",
            "percent": null
        },
        {
            "name": "Basilar artery ischemia",
            "percent": null
        },
        {
            "name": "rare",
            "percent": null
        },
        {
            "name": "Pruritus GI distress",
            "percent": null
        },
        {
            "name": "Skin discoloration",
            "percent": null
        },
        {
            "name": "yellow",
            "percent": null
        },
        {
            "name": "Hives",
            "percent": null
        },
        {
            "name": "Taste disturbance",
            "percent": null
        },
        {
            "name": "Vomiting",
            "percent": null
        },
        {
            "name": "Urine discoloration",
            "percent": null
        },
        {
            "name": "Dermatitis",
            "percent": null
        },
        {
            "name": "Extravasation",
            "percent": null
        },
        {
            "name": "Thrombophlebitis",
            "percent": null
        },
        {
            "name": "Bronchospasm",
            "percent": null
        },
        {
            "name": "Pulmonary edema",
            "percent": null
        },
        {
            "name": "acute",
            "percent": null
        },
        {
            "name": "Respiratory arrest",
            "percent": null
        },
        {
            "name": "Sickle cell crisis",
            "percent": null
        },
        {
            "name": "Localized nerve palsy",
            "percent": null
        },
        {
            "name": "Hemolytic anemia",
            "percent": null
        },
        {
            "name": "Severe shock and death",
            "percent": null
        },
        {
            "name": "rarely",
            "percent": null
        }
    ]
}